Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology

Detalhes bibliográficos
Autor(a) principal: Coimbra, Ibsen Bellini
Data de Publicação: 2019
Outros Autores: Plapler, Pérola Grinberg, Campos, Gustavo Constantino de
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/158016
Resumo: OBJECTIVES: This study aimed to provide evidence for understanding how to treat osteoarthritis (OA) in our country. Therefore, it was necessary to match information and investigations related to the treatment of the disease from the three main types of specialists involved: physiatrists, orthopedists and rheumatologists. METHODS: The authors acted as a scientific advisory committee. From the initial discussions, a structured questionnaire was developed for use with a group of specialists on OA using the Delphi technique. The questionnaire was sent to 21 experts appointed by the authors, and the results obtained were critically analyzed and validated. RESULTS: The prevalence of OA was 33% in Brazil, corresponding to one-third of the individuals in the reference population, which included individuals over 25 years of age. Another significant finding was that most patients did not receive any form of treatment in the early stages of OA. CONCLUSION: The committee pointed to the need for early intervention and that the available medicinal resources can fulfil this important role, as is the case with SYSADOA treatments. Glucosamine-based medicinal products with or without chondroitin could also fulfill this need for early treatment. The other generated evidence and included investigations were then grouped together and are the subject of this publication.
id USP-19_a7cccd80e271a231f27617dadcd059ab
oai_identifier_str oai:revistas.usp.br:article/158016
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodologyOsteoarthritisOsteoarthrosisSurgical TreatmentDrug TherapyGlucosamineChondroitinOBJECTIVES: This study aimed to provide evidence for understanding how to treat osteoarthritis (OA) in our country. Therefore, it was necessary to match information and investigations related to the treatment of the disease from the three main types of specialists involved: physiatrists, orthopedists and rheumatologists. METHODS: The authors acted as a scientific advisory committee. From the initial discussions, a structured questionnaire was developed for use with a group of specialists on OA using the Delphi technique. The questionnaire was sent to 21 experts appointed by the authors, and the results obtained were critically analyzed and validated. RESULTS: The prevalence of OA was 33% in Brazil, corresponding to one-third of the individuals in the reference population, which included individuals over 25 years of age. Another significant finding was that most patients did not receive any form of treatment in the early stages of OA. CONCLUSION: The committee pointed to the need for early intervention and that the available medicinal resources can fulfil this important role, as is the case with SYSADOA treatments. Glucosamine-based medicinal products with or without chondroitin could also fulfill this need for early treatment. The other generated evidence and included investigations were then grouped together and are the subject of this publication.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2019-05-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/clinics/article/view/15801610.6061/clinics/2019/e722Clinics; Vol. 74 (2019); e722Clinics; v. 74 (2019); e722Clinics; Vol. 74 (2019); e7221980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/158016/153260https://www.revistas.usp.br/clinics/article/view/158016/153564Copyright (c) 2019 Clinicsinfo:eu-repo/semantics/openAccessCoimbra, Ibsen BelliniPlapler, Pérola GrinbergCampos, Gustavo Constantino de2019-05-24T13:16:00Zoai:revistas.usp.br:article/158016Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2019-05-24T13:16Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
title Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
spellingShingle Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
Coimbra, Ibsen Bellini
Osteoarthritis
Osteoarthrosis
Surgical Treatment
Drug Therapy
Glucosamine
Chondroitin
title_short Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
title_full Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
title_fullStr Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
title_full_unstemmed Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
title_sort Generating evidence and understanding the treatment of osteoarthritis in Brazil: a study through Delphi methodology
author Coimbra, Ibsen Bellini
author_facet Coimbra, Ibsen Bellini
Plapler, Pérola Grinberg
Campos, Gustavo Constantino de
author_role author
author2 Plapler, Pérola Grinberg
Campos, Gustavo Constantino de
author2_role author
author
dc.contributor.author.fl_str_mv Coimbra, Ibsen Bellini
Plapler, Pérola Grinberg
Campos, Gustavo Constantino de
dc.subject.por.fl_str_mv Osteoarthritis
Osteoarthrosis
Surgical Treatment
Drug Therapy
Glucosamine
Chondroitin
topic Osteoarthritis
Osteoarthrosis
Surgical Treatment
Drug Therapy
Glucosamine
Chondroitin
description OBJECTIVES: This study aimed to provide evidence for understanding how to treat osteoarthritis (OA) in our country. Therefore, it was necessary to match information and investigations related to the treatment of the disease from the three main types of specialists involved: physiatrists, orthopedists and rheumatologists. METHODS: The authors acted as a scientific advisory committee. From the initial discussions, a structured questionnaire was developed for use with a group of specialists on OA using the Delphi technique. The questionnaire was sent to 21 experts appointed by the authors, and the results obtained were critically analyzed and validated. RESULTS: The prevalence of OA was 33% in Brazil, corresponding to one-third of the individuals in the reference population, which included individuals over 25 years of age. Another significant finding was that most patients did not receive any form of treatment in the early stages of OA. CONCLUSION: The committee pointed to the need for early intervention and that the available medicinal resources can fulfil this important role, as is the case with SYSADOA treatments. Glucosamine-based medicinal products with or without chondroitin could also fulfill this need for early treatment. The other generated evidence and included investigations were then grouped together and are the subject of this publication.
publishDate 2019
dc.date.none.fl_str_mv 2019-05-15
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/158016
10.6061/clinics/2019/e722
url https://www.revistas.usp.br/clinics/article/view/158016
identifier_str_mv 10.6061/clinics/2019/e722
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/158016/153260
https://www.revistas.usp.br/clinics/article/view/158016/153564
dc.rights.driver.fl_str_mv Copyright (c) 2019 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/xml
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 74 (2019); e722
Clinics; v. 74 (2019); e722
Clinics; Vol. 74 (2019); e722
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222764156583936